- GlobeNewswire•6 days ago
Momenta Pharmaceuticals Announces Date of First Quarter 2017 Financial Results Conference Call and Webcast
CAMBRIDGE, Mass., April 18, 2017-- Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, will release its financial results for the ...
- Zacks•26 days ago
Momenta (MNTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Investopedia•26 days ago
A month has gone by since the last earnings report for Momenta Pharmaceuticals, Inc. MNTA. Shares have lost about 9.6% in that time frame, underperforming the market. Will the recent negative trend continue ...
MNTA : Summary for Momenta Pharmaceuticals, Inc. - Yahoo Finance
Momenta Pharmaceuticals, Inc. (MNTA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||13.05 x 100|
|Ask||15.65 x 1400|
|Day's Range||13.10 - 13.43|
|52 Week Range||8.82 - 19.90|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-43.63|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|